Urinary Incontinence
Definition
Urinary incontinence (UI) is the involuntary leakage of urine due to loss of bladder control. It is
a symptom rather than a disease and can significantly affect a person's physical, psychological,
social, and emotional well-being.
Causes
1. Weak Pelvic Floor Muscles
Weakening of the pelvic floor muscles due to pregnancy, childbirth, aging, menopause, or
obesity reduces support to the bladder and urethra, leading to urine leakage.
2. Aging
With increasing age, bladder capacity decreases, bladder muscle contractions become less
effective, and urethral sphincter tone weakens, increasing the risk of incontinence.
3. Pregnancy and Childbirth
Hormonal changes and pressure from the growing uterus weaken the pelvic floor muscles.
Vaginal delivery may damage pelvic muscles and nerves controlling urination.
4. Menopause
Reduced estrogen levels cause thinning of the urethral and bladder tissues, decreasing urethral
closure pressure and leading to leakage.
5. Prostate Disorders
Benign prostatic hyperplasia (BPH), prostate cancer, or prostate surgery may obstruct urine flow
or damage sphincter muscles, resulting in incontinence.
6. Neurological Disorders
Diseases such as stroke, Parkinson's disease, multiple sclerosis, spinal cord injury, diabetic
neuropathy, and dementia interfere with nerve control of bladder function.
7. Urinary Tract Infection (UTI)
Inflammation of the bladder irritates the bladder wall, causing urgency, frequency, and
temporary urinary incontinence.
8. Bladder Stones or Tumors
These conditions irritate the bladder lining and may obstruct urine flow, causing leakage.
9. Medications
Diuretics increase urine production, while sedatives, antidepressants, alpha-blockers, and alcohol
may impair bladder control.
10. Chronic Cough
Persistent coughing increases intra-abdominal pressure, weakening the pelvic floor and causing
stress incontinence.
11. Obesity
Excess body weight increases pressure on the bladder and pelvic floor muscles.
12. Constipation
A full rectum presses against the bladder and affects bladder emptying, contributing to urinary
leakage.
Types
1. Stress Urinary Incontinence
Leakage occurs during coughing, sneezing, laughing, lifting heavy objects, or exercise because
increased abdominal pressure overcomes weak urethral closure.
2. Urge Urinary Incontinence
Sudden, intense urge to urinate followed by involuntary leakage due to overactive bladder
muscle contractions.
3. Overflow Urinary Incontinence
Continuous dribbling occurs because the bladder cannot empty completely due to obstruction or
weak bladder muscle.
4. Functional Urinary Incontinence
The urinary system is normal, but physical disability, cognitive impairment, or environmental
barriers prevent timely toileting.
5. Mixed Urinary Incontinence
Combination of stress and urge urinary incontinence.
6. Reflex Urinary Incontinence
Occurs without warning due to neurological damage affecting bladder reflexes.
7. Transient Urinary Incontinence
Temporary incontinence caused by reversible conditions such as UTI, medications, constipation,
or delirium.
Pathophysiology
Normally, urine is stored in the bladder while the detrusor muscle remains relaxed and the
urethral sphincters remain contracted. During urination, the detrusor muscle contracts and the
sphincters relax.
In urinary incontinence, this normal mechanism is disrupted due to weakness of pelvic floor
muscles, sphincter dysfunction, overactivity of the detrusor muscle, bladder outlet obstruction, or
neurological impairment. These abnormalities result in involuntary urine leakage.
Clinical Manifestations
Involuntary leakage of urine
Urinary urgency
Increased urinary frequency
Nocturia
Difficulty delaying urination
Dribbling of urine
Feeling of incomplete bladder emptying
Hesitancy
Weak urinary stream
Leakage during coughing, sneezing, laughing, or lifting
Perineal skin irritation
Recurrent urinary tract infections
Embarrassment
Anxiety
Depression
Social isolation
Sleep disturbance
Diagnostic Evaluation
Health history
Physical examination
Bladder diary
Urinalysis
Urine culture
Post-void residual urine measurement
Pad test
Urodynamic studies
Cystoscopy
Ultrasound of the urinary tract
Neurological examination
Pharmacological Management
Antimuscarinic drugs (e.g., Oxybutynin, Tolterodine, Solifenacin)
Beta-3 adrenergic agonist (Mirabegron)
Topical estrogen (postmenopausal women)
Alpha-adrenergic agonists (selected cases)
Duloxetine (stress urinary incontinence in selected patients)
Antibiotics for urinary tract infection
Management of underlying diseases
Non-Pharmacological Management
Pelvic floor muscle (Kegel) exercises
Bladder training
Timed voiding
Scheduled toileting
Lifestyle modification
Weight reduction
Smoking cessation
Reduce caffeine and alcohol intake
Treat constipation
Adequate fluid intake
Use absorbent pads if necessary
Surgical Management
Mid-urethral sling procedures
Tension-free vaginal tape (TVT)
Transobturator tape (TOT)
Colposuspension
Artificial urinary sphincter implantation
Bulking agent injections
Sacral nerve stimulation
Bladder augmentation (selected cases)
Nursing Management
Assess type and severity of urinary incontinence.
Monitor frequency, volume, and pattern of urination.
Maintain an intake and output chart.
Encourage bladder training and scheduled voiding.
Teach pelvic floor (Kegel) exercises.
Encourage adequate hydration while avoiding bladder irritants.
Maintain perineal hygiene and skin integrity.
Change wet clothing and absorbent pads promptly.
Prevent falls by providing easy toilet access.
Provide emotional support and reassurance.
Educate the patient and family about treatment and lifestyle
modifications.
Administer medications as prescribed.
Monitor response to treatment and report any complications.
Complications
Recurrent urinary tract infections
Perineal skin breakdown
Pressure injuries
Falls and fractures
Sleep disturbances
Anxiety and depression
Social isolation
Reduced quality of life
Prognosis
The prognosis depends on the underlying cause, severity, age, and adherence to treatment. Many
patients improve significantly with lifestyle modifications, bladder training, pelvic floor
exercises, medications, or surgery. Early diagnosis and appropriate management improve
continence, prevent complications, and enhance quality of life.
Pharmacological Management of Urinary Incontinence
The choice of medication depends on the type of urinary incontinence, the patient's age,
associated diseases, and the underlying cause. Medications are mainly effective for urge urinary
incontinence (overactive bladder) and selected cases of stress urinary incontinence.
1. Antimuscarinic (Anticholinergic) Drugs
Examples: Oxybutynin, Tolterodine, Solifenacin, Darifenacin, Fesoterodine, Trospium.
Mechanism of Action: These drugs block muscarinic receptors in the bladder, reducing
involuntary detrusor muscle contractions. This increases bladder capacity and decreases urinary
urgency, frequency, and urge incontinence.
Indications:
Urge urinary incontinence
Overactive bladder
Common Side Effects:
Dry mouth
Constipation
Blurred vision
Dizziness
Urinary retention
Confusion (especially in older adults)
2. Beta-3 Adrenergic Agonist
Example: Mirabegron
Mechanism of Action: Mirabegron stimulates beta-3 adrenergic receptors in the bladder,
relaxing the detrusor muscle during the filling phase. This allows the bladder to hold more urine.
Indications:
Overactive bladder
Urge urinary incontinence
Side Effects:
Increased blood pressure
Headache
Urinary tract infection
Nasopharyngitis
3. Topical Estrogen Therapy
Examples: Vaginal estrogen cream, tablet, or ring.
Mechanism of Action: Improves the thickness and elasticity of the urethral and vaginal tissues,
increasing urethral closure pressure.
Indications:
Postmenopausal women with mild stress or urge urinary incontinence
Side Effects:
Local irritation
Vaginal discharge
4. Duloxetine
Mechanism of Action: Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that
increases urethral sphincter muscle tone during the urine storage phase.
Indications:
Moderate to severe stress urinary incontinence (selected patients)
Side Effects:
Nausea
Dry mouth
Fatigue
Insomnia
Dizziness
5. Alpha-Adrenergic Agonists
Examples: Pseudoephedrine, Phenylephrine
Mechanism of Action: Increase urethral sphincter contraction by stimulating alpha-adrenergic
receptors.
Indications:
Mild stress urinary incontinence (used less commonly)
Side Effects:
Hypertension
Palpitations
Anxiety
Insomnia
6. Antibiotics
Indication: If urinary incontinence is associated with a urinary tract infection, appropriate
antibiotics are prescribed based on urine culture and sensitivity.
7. Treatment of Underlying Conditions
Control diabetes mellitus.
Treat constipation.
Adjust medications such as diuretics if necessary.
Manage neurological disorders whenever possible.
Surgical Management of Urinary Incontinence
Surgery is considered when conservative treatment and medications fail or when there is
significant anatomical abnormality.
1. Mid-Urethral Sling Procedure
A synthetic mesh sling is placed beneath the mid-portion of the urethra to provide support and
prevent urine leakage during activities that increase intra-abdominal pressure.
Indications:
Stress urinary incontinence due to urethral hypermobility
Advantages:
Minimally invasive
High success rate
Quick recovery
2. Tension-Free Vaginal Tape (TVT)
Procedure: A polypropylene mesh tape is inserted through a small vaginal incision and
positioned beneath the urethra without tension.
Indications:
Female stress urinary incontinence
Advantages:
Effective long-term results
Short hospital stay
Complications:
Bleeding
Infection
Bladder injury
Urinary retention
Mesh erosion
3. Transobturator Tape (TOT)
Procedure: A synthetic tape is passed through the obturator foramen to support the urethra.
Indications:
Stress urinary incontinence
Advantages:
Less risk of bladder injury than TVT
Good long-term success
4. Burch Colposuspension
Procedure: The tissues around the bladder neck are sutured to the pelvic ligaments, elevating
and supporting the bladder neck and urethra.
Indications:
Stress urinary incontinence
Patients unsuitable for sling procedures
Advantages:
Effective long-term treatment
5. Artificial Urinary Sphincter (AUS)
Procedure: A fluid-filled cuff is surgically placed around the urethra. The patient controls
urination by pressing a pump implanted in the scrotum (men) or labia (women).
Indications:
Severe intrinsic sphincter deficiency
Post-prostate surgery incontinence
Advantages:
Excellent continence in severe cases
6. Periurethral Bulking Agent Injection
Procedure: Bulking materials (e.g., collagen or synthetic agents) are injected around the urethra
to improve urethral closure.
Indications:
Mild to moderate stress urinary incontinence
Patients not fit for major surgery
Advantages:
Minimally invasive
Outpatient procedure
Disadvantages:
Effect may decrease over time, requiring repeat injections
7. Sacral Nerve Stimulation (Sacral Neuromodulation)
Procedure: A small electrical stimulator is implanted near the sacral nerve (S3) to regulate
bladder nerve signals.
Indications:
Refractory urge urinary incontinence
Overactive bladder not responding to medication
Advantages:
Improves bladder control
Reduces urgency and frequency
8. Bladder Augmentation (Augmentation Cystoplasty)
Procedure: A segment of the intestine is attached to the bladder to increase bladder capacity.
Indications:
Severe neurogenic bladder
Refractory urge urinary incontinence
Advantages:
Increases bladder capacity
Reduces bladder pressure
Complications:
Infection
Mucus production
Bladder stones
Need for intermittent catheterization
Summary
Stress urinary incontinence: Sling procedures (TVT, TOT), Burch
colposuspension, bulking agents, artificial urinary sphincter.
Urge urinary incontinence: Antimuscarinics, Mirabegron, sacral
nerve stimulation, bladder augmentation (selected cases).
Mixed urinary incontinence: Combination of behavioral therapy,
medications, and surgery depending on the predominant symptoms.